USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TOLERO PHARMACEUTICALS, INC.
Address:
2975 W. Executive Parkway
Suite 320
Lehi, UT 84043
Phone:
N/A
URL:
N/A
EIN:
452693385
DUNS:
969849004
Number of Employees:
20
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $200,000.00 1

Award List:

TARGETING BMP SIGNALING WITH TP-0413

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$200,000.00
Agency:
HHS
Principal Investigator:
Steven l. P. Warner – 801-285-7570
Abstract:
TP-0413 is a novel small molecule inhibitor of the BMP pathway that has significant potential to be developed to treat anemia of cancer. Anemia of cancer is cytokine driven and results in the up-regulation of a liver hormone called hepcidin through the function of BMP receptors. Increased hepcidin… More